PCT in the News
The following extracts from the WIPO Magazine (No. 4, 2014) have been added to the “PCT in the News” page of the PCT website:
Bacteria as a Vehicle for Drug Delivery
ActoGeniX, a small Belgian biotech company with a global reach, is breaking new ground in the treatment of gastrointestinal, immunological and metabolic diseases. Their new technology, known as ActobioticsTM, promises to revolutionize the treatment of these chronic conditions. Intellectual property is at the heart of the company’s business strategy enabling it to attract investors, secure a competitive advantage and create value for its shareholders. ActoGeniX uses the PCT to file its patent applications internationally. “The PCT buys us time to determine whether it is really worth pursuing a patent at the national level. This can be a costly affair, so the PCT offers us valuable time and cost savings,” explains Emil Pot, General Counsel at ActoGeniX.
Innovation Gathers Pace in Renewables Sector
Sarah Helm, Manager at UK-based innovation consultancy CambridgeIP, discusses a recent report co-published with WIPO which highlights striking increases in commercial innovation in relation to four climate-change mitigation technologies (CCMTs), namely, biofuels, solar thermal, solar photovoltaic and wind. A marked rise in the use of the PCT points to the increasingly global nature of markets for these patented technologies. Since 2006, over 30% of patents filed within these four areas were filed through the PCT, nearly double the rate of PCT filings between 1975 and 2005.
These and other extracts from the WIPO Magazine are available at:
The WIPO Magazine, Issue No. 4/2014 is available at: